[print
friendly page]
Pentazocine
The effort to find
an effective analgesic with less dependence-producing consequences led
to the development of pentazocine (Talwin®). Introduced as an analgesic
in 1967, it was frequently encountered in the illicit trade, usually in
combination with tripelennamine and placed into Schedule IV of the CSA
in 1979. An attempt at reducing the abuse of this drug was made with the
introduction of Talwin Nx®. This product contains a quantity of
antagonist (naloxone) sufficient to counteract the morphine-like effects
of pentazocine if the tablets are dissolved and injected.
|